(Q38025702)

27 August 2017

Central serous chorioretinopathy: a review of epidemiology and pathophysiology (English)

1 reference

27 August 2017

1 reference

Gerald Liew

1

1 reference

27 August 2017

Godfrey Quin

series ordinal

2

1 reference

27 August 2017

Mark Gillies

series ordinal

3

1 reference

27 August 2017

Samantha Fraser-Bell

series ordinal

4

1 reference

27 August 2017

21 September 2012

1 reference

Clinical and Experimental Ophthalmology

27 August 2017

1 reference

27 August 2017

41

1 reference

27 August 2017

2

1 reference

27 August 2017

201-214

1 reference

Central serous chorioretinopathy

27 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Review and update of central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

[Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy in endogenous hypercortisolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy and white subretinal exudation during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Risk factors for central serous chorioretinopathy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Systemic findings associated with central serous chorioretinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy and risk for obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Familial chronic central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Chorioretinopathia centralis serosa und psychische Belastung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Psychosomatic aspects in patients with central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Effect of catecholamine on central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Endogenous cortisol profile in patients with central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Endocrine abnormalities in patients with central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy as a presenting symptom of endogenous Cushing syndrome: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy after solid organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Two cases of central serous chorioretinopathy treated with photocoagulation after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

21 January 2018

True, true and related?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Corticosteroids and central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Intravitreal triamcinolone acetonide and central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Visual loss from central serous retinopathy in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Obstructive sleep apnea in patients with central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Bilateral central serous chorioretinopathy resolving rapidly with treatment for obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy associated with sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy following oral tadalafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Phosphodiesterase inhibitors and the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Long-term follow-up of central serous retinopathy in 150 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Evaluation of central serous retinopathy with en face optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Long-term follow-up of central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Long-term follow-up of idiopathic central serous chorioretinopathy without laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

High-Resolution Imaging of Resolved Central Serous Chorioretinopathy Using Adaptive Optics Scanning Laser Ophthalmoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

The long-term outcome of central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Acute central serous chorioretinopathy and fundus autofluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Peripheral Retinal Detachments and Retinal Pigment Epithelial Atrophic Tracts Secondary to Central Serous Pigment Epitheliopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

The natural history of pigment epithelial detachment associated with central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy: an update on pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Posterior cystoid retinal degeneration in central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

State-of-the-art retinal optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Fluorescein-angiographic patterns in patients with central serous chorioretinopathy at the initial visit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Pathogenesis of central serous retinopathy: a new working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Digital indocyanine green videoangiography of central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Choroidal capillary and venous congestion in central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Choroidal imaging using spectral-domain optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Autofluorescence from the outer retina and subretinal space: hypothesis and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Fundus autofluorescence and central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Abnormalities of fundus autofluorescence in central serous retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Detection of retinal metabolic stress resulting from central serous retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Central serous chorioretinopathy associated with testosterone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

The potential role of testosterone in central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Finasteride for chronic central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Argon laser photocoagulation in the treatment of central serous retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Chronic central serous chorioretinopathy: photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Photodynamic therapy for chronic central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Photodynamic therapy for steroid-associated central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Eight-year follow-up of central serous chorioretinopathy with and without laser treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Oral mifepristone for chronic central serous chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

A case of chronic severe central serous chorioretinopathy responding to oral mifepristone: update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2012.02848.X

10.1111/J.1442-9071.2012.02848.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference